Please assess the completion status of the following clinical trial:

Trial Title: Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* Patients with CRPC progressing during the course of first line docetaxel-based chemotherapy or after at least 3 cycles (equivalent to 225mg/m2) of first line docetaxel-based chemotherapy~* Patient who have given their written consent~Exclusion criteria:~* Current participation in a clinical trial for the second-line treatment of prostate cancer~* Patients having received less than 3 cycles of first line docetaxel-based chemotherapy and discontinued for a reason other than disease progression or toxicity~* Patients having already started a second line treatment~The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

- Gender: MALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CRPC patients (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).